| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.011 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |